Research Article

Prevalence of Diabetic Foot Disease in Patients with Diabetes Mellitus under Renal Replacement Therapy in Lleida, Spain

Table 3

Bivariate and multivariate analysis for risk factors associated with lower-limb amputations.

Risk factorAmputations⁢Bivariate analysisMultivariate analysis
YesNoRR/mean diff. (95% CI) valueAdjusted value

Gender, (%)
 Male10 (17.5)47 (82.5)1.22 (0.45–3.29)0.70
 Female5 (14.3)30 (85.7)
Age (years), mean (SD)72.3 (10.3)70.6 (12.4)1.69 (−4.50–7.89)0.74
Diabetes, (%)
 Type 11.0 (9.0)10 (90.9)0.52 (0.07–3.61)0.78
 Type 214 (17.3)67 (82.7)
Diabetes duration (years), mean (SD)23.9 (13.6)22.0 (12.0)1.90 (−6.00–9.81)0.79
Dialysis duration, mean (SD)5.5 (5.9)4.6 (3.9)0.81 (−2.55–4.18)0.92
Current or former smoker, (%)
 Yes6 (15)34 (85)0.86 (0.33–2.23)0.78
 No9 (17.3)43 (82.7)
Dyslipidaemia, (%)
 Yes10 (15.9)53 (84.1)0.92 (0.34–2.45)0.85
 No5 (17.2)43 (82.8)
Hypertension, (%)
 Yes14 (18.0)64 (82.1)2.51 (0.35–17.61)0.35
 No1 (7.14)13 (92.9)
Retinopathy, (%)
 Yes15 (26.3)42 (73.7)3.94 (ne)0.020.023
 No0 (0.0)14 (100.0)
Amaurosis, (%)
 Yes2 (18.8)9 (81.8)0.85 (0.22–3.26)0.86
 No13 (12.3)48 (78.7)
Stroke, (%)
 Yes2 (20.0)8 (80.0)1.26 (0.33–4.79)0.71
 No13 (15.9)69 (84.1)
IHD, (%)
 Yes4 (19.1)17 (81.0)1.21 (0.43–3.46)0.69
 No11 (15.5)60 (84.5)
PN
 Yes15 (8.3)67 (81.7)1.64 (ne)0.21
 No0 (0.0)8 (100.0)
PAD, (%)
 Yes9 (17.7)42 (83.4)1.47 (0.34–6.29)0.31
 No2 (8.3)22 (91.7)
Foot deformities, (%)
 Yes6 (12.0)44 (88.0)0.510.24
 No9 (21.4)33 (78.6)
AD, (%)
 AD37 (20.0)28 (80.0)1.84 (0.63–5.31)0.27
 AD1 or AD25 (10.9)41 (89.1)
Carotid plaques, (%)
 Stenosing3 (50.0)3 (50)4.62 (1.64–13)0.030.12
 Nonstenosing8 (10.8)66 (89.2)
IMT, mean (SD)0.9 (0.2)0.9 (0.2)0.009 (−0.11–0.13)0.97

AD, atheromatous disease; IHD, ischaemic heart disease; IMT, intima-media thickness; ne, nonestimable; PAD, peripheral artery disease; PN, peripheral neuropathy; RR, risk ratio.